Benjamin Porter-Brown
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in ⓘ
-
- Rheumatoid Arthritis Research and Therapies 8
- Spondyloarthritis Studies and Treatments 2
-
- Psoriasis: Treatment and Pathogenesis 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Co-authors
- Liz Thompson (3 shared papers)Olivier Harari (2 shared papers)Maxime Dougados (2 shared papers)Joachim Sieper (1 shared paper)Ronald van Vollenhoven (3 shared papers)Anthony Sebba (3 shared papers)Andrea Rubbert‐Roth (3 shared papers)Pavel Napalkov (3 shared papers)
- Journals
- Annals of the Rheumatic Diseases (2 papers)Lara D. Veeken (2 papers)Seminars in Arthritis and Rheumatism (1 paper)Arthritis & Rheumatology (1 paper)RMD Open (1 paper)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Benjamin Porter-Brown
10 papers receiving 384 citations
Peers
Comparison fields: 5 of 52
- Rheumatology 264
- Hematology 142
- Immunology 160
- Genetics 26
- Pathology and Forensic Medicine 32
Countries citing papers authored by Benjamin Porter-Brown
This map shows the geographic impact of Benjamin Porter-Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Porter-Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Porter-Brown more than expected).
Fields of papers citing papers by Benjamin Porter-Brown
This network shows the impact of papers produced by Benjamin Porter-Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Porter-Brown. The network helps show where Benjamin Porter-Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Porter-Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 158 | |
| 2 | 2016 | 66 | |
| 3 | 2016 | 45 | |
| 4 | 2017 | 40 | |
| 5 | 2014 | 38 | |
| 6 | 2012 | 18 | |
| 7 | 2019 | 14 | |
| 8 | Tofacitinib (cp-690,550), an oral Janus Kinase Inhibitor: Pooled phase 3 analysis in an Australian Rheumatoid Arthritis Study Population | 2012 | 6 |
| 9 | 2014 | 6 | |
| 10 | 2014 | 3 |
About Benjamin Porter-Brown
Benjamin Porter-Brown is a scholar working on Rheumatology, Immunology, Hematology, Molecular Biology and Pathology and Forensic Medicine, having authored 10 papers that have together received 394 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Inflammasome and immune disorders (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Rheumatology (264 citations), Hematology (142 citations), Immunology (160 citations), Genetics (26 citations) and Pathology and Forensic Medicine (32 citations). Benjamin Porter-Brown has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Liz Thompson, Olivier Harari, Maxime Dougados, Joachim Sieper, Ronald van Vollenhoven, Anthony Sebba, Andrea Rubbert‐Roth, Pavel Napalkov, Francis Donaldson and Andrew J.K. Östör. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Seminars in Arthritis and Rheumatism, Arthritis & Rheumatology and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.